Related Experiment Video
Updated: Mar 30, 2026

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Merkel Cell Polyomavirus Small T Antigen Induces Cancer and Embryonic Merkel Cell Proliferation in a Transgenic Mouse
Masahiro Shuda1, Anna Guastafierro1, Xuehui Geng2
1Cancer Virology Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Abstract:
Merkel cell polyomavirus (MCV) causes the majority of human Merkel cell carcinomas (MCC) and encodes a small T (sT) antigen that transforms immortalized rodent fibroblasts in vitro. To develop a mouse model for MCV sT-induced carcinogenesis, we generated transgenic mice with a flox-stop-flox MCV sT sequence homologously recombined at the ROSA locus (ROSAsT), allowing Cre-mediated, conditional MCV sT expression. Standard tamoxifen (TMX) administration to adult UbcCreERT2; ROSAsT mice, in which Cre is ubiquitously expressed, resulted in MCV sT expression in multiple organs that was uniformly lethal within 5 days. Conversely, most adult UbcCreERT2; ROSAsT mice survived low-dose tamoxifen administration but developed ear lobe dermal hyperkeratosis and hypergranulosis. Simultaneous MCV sT expression and conditional homozygous p53 deletion generated multi-focal, poorly-differentiated, highly anaplastic tumors in the spleens and livers of mice after 60 days of TMX treatment. Mouse embryonic fibroblasts from these mice induced to express MCV sT exhibited anchorage-independent cell growth. To examine Merkel cell pathology, MCV sT expression was also induced during mid-embryogenesis in Merkel cells of Atoh1CreERT2/+; ROSAsT mice, which lead to significantly increased Merkel cell numbers in touch domes at late embryonic ages that normalized postnatally. Tamoxifen administration to adult Atoh1CreERT2/+; ROSAsT and Atoh1CreERT2/+; ROSAsT; p53flox/flox mice had no effects on Merkel cell numbers and did not induce tumor formation. Taken together, these results show that MCV sT stimulates progenitor Merkel cell proliferation in embryonic mice and is a bona fide viral oncoprotein that induces full cancer cell transformation in the p53-null setting.
Insights
Merkel cell polyomavirus small T antigen drives cancer. Conditional expression in mice revealed its oncogenic potential, particularly in p53-deficient settings, leading to tumor formation and cell transformation.
Area of Science:
- Oncology
- Virology
- Genetics
Background:
- Merkel cell polyomavirus (MCV) is a primary cause of Merkel cell carcinoma (MCC).
- The MCV small T (sT) antigen possesses transforming capabilities in vitro.
- A conditional mouse model is needed to study MCV sT-induced carcinogenesis in vivo.
Purpose of the Study:
- To develop and characterize a conditional transgenic mouse model for MCV sT-induced carcinogenesis.
- To investigate the oncogenic role of MCV sT in different cellular and genetic contexts.
- To explore the impact of MCV sT on Merkel cell development and tumorigenesis.
Main Methods:
- Generation of ROSAsT transgenic mice with conditional MCV sT expression.
- Tamoxifen-inducible Cre-mediated recombination for spatio-temporal control of sT expression.
- Analysis of tumor development in wild-type and p53-deficient mice.
- Assessment of Merkel cell proliferation during embryogenesis.
Main Results:
- Ubiquitous MCV sT expression in adult mice led to rapid lethality or non-specific hyperplasia.
- Conditional sT expression in p53-null mice induced aggressive, multi-focal tumors in spleen and liver.
- MCV sT expression in embryonic progenitor Merkel cells increased their numbers transiently.
- Mouse embryonic fibroblasts expressing MCV sT exhibited anchorage-independent growth.
Conclusions:
- MCV sT is a potent viral oncoprotein capable of inducing full cancer cell transformation.
- The p53 tumor suppressor pathway is critical in suppressing MCV sT-driven tumorigenesis.
- MCV sT can influence progenitor cell proliferation during development, but tumorigenesis requires specific conditions.
More Related Videos
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019